Suchergebnisse - "Shang, Yanhong"

PubPharm (52)

1

Cullin7 induces docetaxel resistance by regulating the protein level of the antiapoptotic protein Survivin in lung adenocarcinoma cells

enthalten in: Journal of thoracic disease | 2023

von Li, Y. | He, W. | Gao, X. | +9

2

Application of malic acid and derivative thereof in preparation of metallo-beta-lactamase sensitizer, composition and application thereof

enthalten in: Europäisches Patentamt | 2023

von LEE DUCK-HEE | DU XIANGDANG | WANG YIXIN | +6

3

Application of malic acid and derivative thereof in preparation of metallo-beta-lactamase sensitizer, composition and application thereof

enthalten in: Europäisches Patentamt | 2023

von LEE DUCK-HEE | DU XIANGDANG | WANG YIXIN | +6

4

Pharmaceutical composition for sensitizing drug-resistant bacteria and application of pharmaceutical composition

enthalten in: Europäisches Patentamt | 2023

von LEE DUCK-HEE | DU XIANGDANG | CHANG LIJUAN | +6

5

Pharmaceutical composition for sensitizing drug-resistant bacteria and application of pharmaceutical composition

enthalten in: Europäisches Patentamt | 2023

von LEE DUCK-HEE | DU XIANGDANG | CHANG LIJUAN | +6

6

Radionecrosis mimicking pseudo‑progression in a patient with lung cancer and brain metastasis following the combination of anti‑PD‑1 therapy and stereotactic radiosurgery : A case report

enthalten in: Oncology letters | 2023

von Ji, X. | Wang, L. | Tan, Y. | +5

7

Anlotinib plus icotinib as a potential treatment option for EGFR-mutated advanced non-squamous non-small cell lung cancer with concurrent mutations : final analysis of the prospective phase 2, multicenter ALTER-L004 study

enthalten in: Molecular cancer | 2023

von Zhang, L. | Wang, L. | Wang, J. | +15

8

Anlotinib plus icotinib as a potential treatment option for EGFR-mutated advanced non-squamous non-small cell lung cancer with concurrent mutations: final analysis of the prospective phase 2, multicenter ALTER-L004 study

enthalten in: Molecular cancer | 2023

von Zhang, L. | Wang, L. | Wang, J. | +15

9

Anlotinib plus icotinib as a potential treatment option for EGFR-mutated advanced non-squamous non-small cell lung cancer with concurrent mutations: final analysis of the prospective phase 2, multicenter ALTER-L004 study

enthalten in: Molecular cancer | 2023

von Zhang, L. | Wang, L. | Wang, J. | +15

10

Lyase capable of killing streptococcus suis and medical method thereof

enthalten in: Europäisches Patentamt | 2023

von DU XIANGDANG | LI CHENGLONG | SHANG YANHONG | +1

1
2
3
4
5
6
Nächster »
[6]